Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Igor L. Shamovsky is active.

Publication


Featured researches published by Igor L. Shamovsky.


European Journal of Neuroscience | 1998

RECIPROCAL MODULATION OF TRKA AND P75NTR AFFINITY STATES IS MEDIATED BY DIRECT RECEPTOR INTERACTIONS

Gregory M. Ross; Igor L. Shamovsky; Gail Lawrance; Mark Solc; Suzanne M. Dostaler; Donald F. Weaver; Richard J. Riopelle

Equilibrium binding of 125I‐nerve growth factor (125I‐NGF) to cells coexpressing the tyrosine kinase receptor A (TrkA) and common neurotrophin receptor (p75NTR), cells coexpressing both receptors where p75NTR is occupied, and cells expressing only p75NTR, revealed reciprocal modulation of receptor affinity states. Analysis of receptor affinity states in PC12 cells, PC12 cells in the presence of brain‐derived neurotrophic factor (BDNF), and PC12nnr5 cells suggested that liganded and unliganded p75NTR induce a higher affinity state within TrkA, while TrkA induces a lower affinity state within p75NTR. These data are consistent with receptor allosterism, and prompted a search for TrkA/p75NTR complexes in the absence of NGF. Chemical crosslinking studies revealed high molecular weight receptor complexes that specifically bound 125I‐NGF, and were immunoprecipitated by antibodies to both receptors. The heteroreceptor complex of TrkA and p75NTR alters conformation and/or dissociates in the presence of NGF, as indicated by the ability of low concentrations of NGF to prevent heteroreceptor crosslinking. These data suggest a new model of receptor interaction, whereby structural changes within a heteroreceptor complex are induced by ligand binding.


Journal of the American Chemical Society | 2011

Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2.

Igor L. Shamovsky; Lena Ripa; Lena Börjesson; Christine Mee; Bo Nordén; Peter J. Hansen; Catrin Hasselgren; Mike O’Donovan; Peter Sjö

Aromatic and heteroaromatic amines (ArNH(2)) represent a class of potential mutagens that after being metabolically activated covalently modify DNA. Activation of ArNH(2) in many cases starts with N-hydroxylation by P450 enzymes, primarily CYP1A2. Poor understanding of structure-mutagenicity relationships of ArNH(2) limits their use in drug discovery programs. Key factors that facilitate activation of ArNH(2) are revealed by exploring their reaction intermediates in CYP1A2 using DFT calculations. On the basis of these calculations and extensive analysis of structure-mutagenicity data, we suggest that mutagenic metabolites are generated by ferric peroxo intermediate, (CYP1A2)Fe(III)-OO(-), in a three-step heterolytic mechanism. First, the distal oxygen of the oxidant abstracts proton from H-bonded ArNH(2). The subsequent proximal protonation of the resulting (CYP1A2)Fe(III)-OOH weakens both the O-O and the O-H bonds of the oxidant. Heterolytic cleavage of the O-O bond leads to N-hydroxylation of ArNH(-) via S(N)2 mechanism, whereas cleavage of the O-H bond results in release of hydroperoxy radical. Thus, our proposed reaction offers a mechanistic explanation for previous observations that metabolism of aromatic amines could cause oxidative stress. The primary drivers for mutagenic potency of ArNH(2) are (i) binding affinity of ArNH(2) in the productive binding mode within the CYP1A2 substrate cavity, (ii) resonance stabilization of the anionic forms of ArNH(2), and (iii) exothermicity of proton-assisted heterolytic cleavage of N-O bonds of hydroxylamines and their bioconjugates. This leads to a strategy for designing mutagenicity free ArNH(2): Structural alterations in ArNH(2), which disrupt geometric compatibility with CYP1A2, hinder proton abstraction, or strongly destabilize the nitrenium ion, in this order of priority, prevent genotoxicity.


Journal of Neurochemistry | 2001

The binding of zinc and copper ions to nerve growth factor is differentially affected by pH: implications for cerebral acidosis

Gregory M. Ross; Igor L. Shamovsky; Sang B. Woo; Joan I. Post; Philip N. Vrkljan; Gail Lawrance; Mark Solc; Suzanne M. Dostaler; Kenneth E. Neet; Richard Riopelle

It has recently been shown that transition metal cations Zn2+ and Cu2+ bind to histidine residues of nerve growth factor (NGF) and other neurotrophins (a family of proteins important for neuronal survival) leading to their inactivation. Experimental data and theoretical considerations indicate that transition metal cations may destabilize the ionic form of histidine residues within proteins, thereby decreasing their pKa values. Because the release of transition metal cations and acidification of the local environment represent important events associated with brain injury, the ability of Zn2+ and Cu2+ to bind to neurotrophins in acidic conditions may alter neuronal death following stroke or as a result of traumatic injury. To test the hypothesis that metal ion binding to neurotrophins is influenced by pH, the effects of Zn2+ and Cu2+ on NGF conformation, receptor binding and NGF tyrosine kinase (trkA) receptor signal transduction were examined under conditions mimicking cerebral acidosis (pH range 5.5–7.4). The inhibitory effect of Zn2+ on biological activities of NGF is lost under acidic conditions. Conversely, the binding of Cu2+ to NGF is relatively independent of pH changes within the studied range. These data demonstrate that Cu2+ has greater binding affinity to NGF than Zn2+ at reduced pH, consistent with the higher affinity of Cu2+ for histidine residues. These findings suggest that cerebral acidosis associated with stroke or traumatic brain injury could neutralize the Zn2+‐mediated inactivation of NGF, whereas corresponding pH changes would have little or no influence on the inhibitory effects of Cu2+. The importance of His84 of NGF for transition metal cation binding is demonstrated, confirming the involvement of this residue in metal ion coordination.


Neurotoxicity Research | 2000

Differential effects of transition metal cations on the conformation and biological activities of nerve growth factor

Rajatavo Maitra; Igor L. Shamovsky; Wei Wang; Mark Solc; Gail Lawrance; Suzanne M. Dostaler; Gregory M. Ross; Richard J. Riopelle

Direct effects of Zn2+ on the conformation and biological activity of nerve growth factor (NGF) have previously been described. Zn2+ binds to specific coordination sites within NGF and induces conformational changes within domains that participate in receptor recognition processes. Recent theoretical considerations indicate that other transition metal cations (particularly, Cu2+and Pd2+) are capable of forming similar complexes with NGF. Inactivation of NGF by transition metal cations is inhibitory to neuronal regeneration and sprouting, and can lead to cell death under conditions where NGF is required for survival in PC12 cells. In this study we investigated the influence of various metal ions on NGF conformation, geometry of NGF amino terminal peptide and NGF-mediated biological effects in FC12 cells. A number of metal ions (Zn2+, Cu2+ and Pd2+) alter NGF conformation in cell-free assays and inhibit NGF-mediated cell survival. Other metals have been shown to be either toxic to PC12 cells by mechanisms independent of NGF activity (e.g. Ag+, Hg2+) or non-toxic to the cells under conditions tested (e.g. Al3+, Cr3+). In conclusion, several metal cations are capable of inhibiting NGF activity, thereby blocking NGF-mediated cell survival and plasticity.


Chemical Research in Toxicology | 2012

Theoretical studies of chemical reactivity of metabolically activated forms of aromatic amines toward DNA.

Igor L. Shamovsky; Lena Ripa; Niklas Blomberg; Leif A. Eriksson; Peter J. Hansen; Christine Mee; Christian Tyrchan; Michael R. O'Donovan; Peter Sjö

The metabolism of aromatic and heteroaromatic amines (ArNH₂) results in nitrenium ions (ArNH⁺) that modify nucleobases of DNA, primarily deoxyguanosine (dG), by forming dG-C8 adducts. The activated amine nitrogen in ArNH⁺ reacts with the C8 of dG, which gives rise to mutations in DNA. For the most mutagenic ArNH₂, including the majority of known genotoxic carcinogens, the stability of ArNH⁺ is of intermediate magnitude. To understand the origin of this observation as well as the specificity of reactions of ArNH⁺ with guanines in DNA, we investigated the chemical reactivity of the metabolically activated forms of ArNH₂, that is, ArNHOH and ArNHOAc, toward 9-methylguanine by DFT calculations. The chemical reactivity of these forms is determined by the rate constants of two consecutive reactions leading to cationic guanine intermediates. The formation of ArNH⁺ accelerates with resonance stabilization of ArNH⁺, whereas the formed ArNH⁺ reacts with guanine derivatives with the constant diffusion-limited rate until the reaction slows down when ArNH⁺ is about 20 kcal/mol more stable than PhNH⁺. At this point, ArNHOH and ArNHOAc show maximum reactivity. The lowest activation energy of the reaction of ArNH⁺ with 9-methylguanine corresponds to the charge-transfer π-stacked transition state (π-TS) that leads to the direct formation of the C8 intermediate. The predicted activation barriers of this reaction match the observed absolute rate constants for a number of ArNH⁺. We demonstrate that the mutagenic potency of ArNH₂ correlates with the rate of formation and the chemical reactivity of the metabolically activated forms toward the C8 atom of dG. On the basis of geometric consideration of the π-TS complex made of genotoxic compounds with long aromatic systems, we propose that precovalent intercalation in DNA is not an essential step in the genotoxicity pathway of ArNH₂. The mechanism-based reasoning suggests rational design strategies to avoid genotoxicity of ArNH₂ primarily by preventing N-hydroxylation of ArNH₂.


Chemical Research in Toxicology | 2014

Theoretical studies of the mechanism of N-hydroxylation of primary aromatic amines by cytochrome P450 1A2: radicaloid or anionic?

Lena Ripa; Christine Mee; Peter Sjö; Igor L. Shamovsky

Primary aromatic and heteroaromatic amines are notoriously known as potential mutagens and carcinogens. The major event of the mechanism of their mutagenicity is N-hydroxylation by P450 enzymes, primarily P450 1A2 (CYP1A2), which leads to the formation of nitrenium ions that covalently modify nucleobases of DNA. Energy profiles of the NH bond activation steps of two possible mechanisms of N-hydroxylation of a number of aromatic amines by CYP1A2, radicaloid and anionic, are studied by dispersion-corrected DFT calculations. The classical radicaloid mechanism is mediated by H-atom transfer to the electrophilic ferryl-oxo intermediate of the P450 catalytic cycle (called Compound I or Cpd I), whereas the alternative anionic mechanism involves proton transfer to the preceding nucleophilic ferrous-peroxo species. The key structural features of the catalytic site of human CYP1A2 revealed by X-ray crystallography are maintained in calculations. The obtained DFT reaction profiles and additional calculations that account for nondynamical electron correlation suggest that Cpd I has higher thermodynamic drive to activate aromatic amines than the ferrous-peroxo species. Nevertheless, the anionic mechanism is demonstrated to be consistent with a variety of experimental observations. Thus, energy of the proton transfer from aromatic amines to the ferrous-peroxo dianion splits aromatic amines into two classes with different mutagenicity mechanisms. Favorable or slightly unfavorable barrier-free proton transfer is inherent in compounds that undergo nitrenium ion mediated mutagenicity. Monocyclic electron-rich aromatic amines that do not follow this mutagenicity mechanism show significantly unfavorable proton transfer. Feasibility of the entire anionic mechanism is demonstrated by favorable Gibbs energy profiles of both chemical steps, NH bond activation, and NO bond formation. Taken together, results suggest that the N-hydroxylation of aromatic amines in CYP1A2 undergoes the anionic mechanism. Possible reasons for the apparent inability of Cpd I to activate aromatic amines in CYP1A2 are discussed.


Archive | 2002

Molecular Modeling of the Interaction of Neurotrophins with the P75 NTR Common Neurotrophin Receptor

Igor L. Shamovsky; Gregory M. Ross; Richard J. Riopelle; Donald F. Weaver

Neurotrophins are a family of proteins with pleiotropic effects mediated by two distinct receptor types, namely the trk family and the common neurotrophin receptor p75 NTR Binding of four mammalian neurotrophins, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5), to p75 NTR is studied by large scale molecular dynamics simulations using CHARMM force field. Geometric match of neurotrophin/receptor binding domains in the complexes is evaluated by the Lawrence & Colman’s shape complementarity statistic S c. The model of neurotrophin/receptor interactions suggests that the receptor binding domains of neurotrophins (loops I and IV) are geometrically and electrostatically complementary to a putative binding site of p75 NTR formed by the second and part of the third cysteine-rich domains. All charged residues within the loops I and IV of the neurotrophins, previously determined as being critical for p75 NTR binding, directly participate in receptor binding in the framework of the model. Principal residues of the binding site of p75 NTR include Asp 47, Lys 56, Asp 75, Asp 76, Asp 88 and Glu 89. The additional involvement of Arg 80 and Glu 73 is specific for NGF and BDNF, respectively, and Glu 73 participates in binding with NT-3 and NT-4/5. The model developed has utility in computer-aided molecular design.


Nature Medicine | 1997

Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins.

Gregory M. Ross; Igor L. Shamovsky; Gail Lawrance; Mark Solc; Suzanne M. Dostaler; Sandra L. Jimmo; Donald F. Weaver; Richard J. Riopelle


Archive | 1997

Molecular modelling of neurotrophin-receptor binding

Igor L. Shamovsky; Gregory M. Ross; Richard J. Riopelle; Donald F. Weaver


Archive | 2000

Method of inhibiting neurotrophin-receptor binding

Gregory M. Ross; Igor L. Shamovsky; Sandra Marone; Donald F. Weaver; Richard J. Riopelle

Collaboration


Dive into the Igor L. Shamovsky's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge